Geron Ownership | Who Owns Geron?
Geron Ownership Summary
Geron is owned by 23.06% institutional investors, 0.10% insiders, and 76.84% retail investors. Blackrock is the largest institutional shareholder, holding 7.71% of GERN shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.84% of its assets in Geron shares.
GERN Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Geron | 23.06% | 0.10% | 76.84% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock | 46.55M | 7.71% | $197.38M |
| Blackrock funding, inc. /de | 49.86M | 7.53% | $176.50M |
| Vanguard group | 33.54M | 5.07% | $118.73M |
| Ra capital management | 30.01M | 4.53% | $106.23M |
| Vivo capital | 27.23M | 4.11% | $96.38M |
| Janus henderson group | 27.08M | 4.09% | $95.77M |
| State street | 22.55M | 3.74% | $95.61M |
| Holocene advisors, lp | 22.20M | 3.35% | $78.57M |
| Adage capital partners gp | 21.80M | 3.29% | $77.17M |
| Fmr | 14.33M | 2.16% | $50.74M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Vivo capital | 27.23M | 10.80% | $96.38M |
| Lion point capital, lp | 500.00K | 9.27% | $1.77M |
| Exome asset management | 1.56M | 4.22% | $5.62M |
| Nan fung group | 1.37M | 4.16% | $4.86M |
| Ally bridge group (ny) | 1.07M | 3.26% | $3.80M |
| Darwin global management | 9.57M | 3.21% | $33.88M |
| Bridger management | 1.34M | 2.54% | $4.74M |
| First turn management | 3.89M | 2.47% | $13.78M |
| Vestal point capital, lp | 11.00M | 2.31% | $38.94M |
| Tri locum partners lp | 2.47M | 1.81% | $8.75M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 11.00M | 2.31% | 9.95M |
| Braidwell lp | 7.01M | 0.74% | 7.01M |
| Blackrock | 46.55M | 0.00% | 5.14M |
| Woodline partners lp | 11.59M | 0.28% | 4.55M |
| Janus henderson group | 27.08M | 0.05% | 4.52M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Rtw investments, lp | - | - | -44.11M |
| Tcg crossover management | - | - | -17.39M |
| Darwin global management | 9.57M | 3.21% | -12.47M |
| Bioimpact capital | - | - | -10.48M |
| State street | 22.55M | 0.00% | -9.06M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Braidwell lp | 7.01M | 0.74% | 7.01M | $24.80M |
| Tri locum partners lp | 2.47M | 1.81% | 2.47M | $8.75M |
| Logos global management lp | 2.00M | 0.83% | 2.00M | $7.08M |
| Point72 asset management | 1.49M | 0.01% | 1.49M | $5.27M |
| Natixis | 1.21M | 0.03% | 1.21M | $4.29M |
Sold Out
| Holder | Change |
|---|---|
| Smartleaf asset management | -64.00 |
| Nelson, van denburg & campbell wealth management group | -96.00 |
| Cva family office | -129.00 |
| Principal securities | -150.00 |
| Capital performance advisors llp | -152.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 123 | -53.58% | 152,695,838 | -69.98% | 23 | 0.39% | 60 | -54.89% | 24 | -58.62% |
| Sep 30, 2024 | 264 | 7.32% | 508,658,981 | 9.50% | 76 | 1.52% | 132 | -4.35% | 58 | 13.73% |
| Jun 30, 2024 | 244 | 2.52% | 464,410,765 | 7.02% | 76 | 1.49% | 137 | 16.10% | 51 | -16.39% |
| Mar 31, 2024 | 238 | 14.42% | 433,927,613 | 10.37% | 71 | 1.65% | 118 | 24.21% | 61 | 24.49% |
| Dec 31, 2023 | 208 | 0.48% | 393,141,349 | 6.01% | 66 | 1.61% | 95 | -14.41% | 49 | 44.12% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 18.07M | 2.84% | 15.92K |
| Vanguard US Total Market Shares ETF | 17.83M | 2.80% | 17.67K |
| iShares Russell 2000 ETF | 15.53M | 2.44% | -134.53K |
| SPDR® S&P Biotech ETF | 10.80M | 1.70% | -115.72K |
| Vanguard Institutional Extnd Mkt Idx Tr | 8.00M | 1.26% | 12.16K |
| Eventide Healthcare & Life Sciences I | 7.07M | 1.11% | - |
| Fidelity Small Cap Index | 5.84M | 0.92% | -109.30K |
| Fidelity Growth Compy Commingled Pl S | 5.52M | 0.87% | 8.77K |
| Fidelity Growth Compy Commingled Pl O | 4.29M | 0.71% | - |
| iShares Biotechnology ETF | 3.82M | 0.60% | -42.53K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 27, 2025 | Samuels Scott Alan | EVP, Chief Legal Officer | Buy | $24.15K |
| Feb 27, 2025 | SCARLETT JOHN A | Chairman, President and CEO | Buy | $22.06K |
| Feb 27, 2025 | Ziegler James | EVP, Chief Commercial Officer | Buy | $160.00K |
| Jul 08, 2024 | GRETHLEIN ANDREW J | EVP, Chief Operating Officer | Sell | $3.07M |
| Jun 10, 2024 | Feller Faye | EVP, Chief Medical Officer | Sell | $1.33M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | 3 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 4 |
| 2024 Q1 | - | - |
GERN Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools